| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Finance And Controller | VP, Finance &Controller
1 company
Lam Karen C serves as a VP, Finance And Controller at RAPT. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $358K at current prices.
The biggest single holding is RAPT (~$358K) as VP, Finance And Controller. The recent filings there lean toward selling, a net 4,728 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2020 | RAPT Rapt Therapeutics, Inc. | VP, Finance And Controller | Sell | 2,022 | $28.14 | $56,899.08 | -13.7% | |
| Jun 25, 2020 | RAPT Rapt Therapeutics, Inc. | VP, Finance &Controller | Sell | 875 | $35.00 | $30,625.00 | -6.4% | |
| May 7, 2020 | RAPT Rapt Therapeutics, Inc. | VP, Finance &Controller | Sell | 1,831 | $15.40 | $28,197.40 | -14.5% |